Definium Therapeutics (DFTX) Q3 2026 Earnings

6AugConfirmed
Q4 2025
Q2 2026
Next
-0.78
-0.68
-0.59
-0.49

Details

Expected EPS
-0.56
Actual EPS
N/A
Surprise EPS
0.56
Surprise Percent
+100%

Description

Definium Therapeutics (DFTX) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts